Prevalence of pain in Parkinson's disease: A systematic review using the modified QUADAS tool
暂无分享,去创建一个
Wim E J Weber | P. Martínez-Martín | J. Patijn | M. Broen | W. Weber | J Patijn | Martijn P G Broen | Meriam M Braaksma | Meriam M. Braaksma | Maren E. Bodden | M. P. Broen
[1] A. Auchus,et al. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. , 2002, Parkinsonism & related disorders.
[2] J. Charcot. Lectures on the Localisation of Cerebral and Spinal Diseases: Delivered at the Faculty of Medicine of Paris... , 2010 .
[3] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[4] G. Halliday,et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. , 2002, Brain : a journal of neurology.
[5] P. Leigh,et al. Relationships between Lewy bodies and pale bodies in Parkinson's disease , 2004, Acta Neuropathologica.
[6] J. Parkinson. An Essay on the Shaking Palsy , 2002 .
[7] B. Boeve,et al. α-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals , 2006, Neurology.
[8] L. Metman,et al. Cardiac Sympathetic Denervation in Parkinson Disease , 2000, Annals of Internal Medicine.
[9] C. van Weel,et al. Symptoms and duration of the prodromal phase in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[10] James Parkinson,et al. An essay on the shaking palsy. 1817. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[11] Ralf Baron,et al. Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.
[12] J. Geddes. α-Synuclein: A potent inducer of tau pathology , 2005, Experimental Neurology.
[13] E. Quigley,et al. Characterization of swallowing and defecation in Parkinson's disease. , 1994, The American journal of gastroenterology.
[14] A. Brnabic,et al. Musculoskeletal disability among elderly people in the community , 1998, The Medical journal of Australia.
[15] K. Gwinn‐Hardy,et al. Pain in Parkinson's disease , 2001, Postgraduate medicine.
[16] G. Halliday,et al. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. , 2000, Brain : a journal of neurology.
[17] E. Masliah,et al. Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.
[18] C. Berridge,et al. The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.
[19] A. Kakita,et al. Degeneration of Cardiac Sympathetic Nerve Begins in the Early Disease Process of Parkinson’s Disease , 2007, Brain pathology.
[20] N. Horwitz. Lectures on the diseases of the nervous system. Jean Martin Charcot. Lectures on the localisation of cerebral and spinal diseases. Jean Martin Charcot. , 1995, Neurosurgery.
[21] R. Doty. The olfactory vector hypothesis of neurodegenerative disease: Is it viable? , 2008, Annals of neurology.
[22] Blair H. Smith,et al. The epidemiology of chronic pain in the community , 1999, The Lancet.
[23] R. Wilson,et al. Salivary symptoms in Parkinson disease. , 1973, Archives of neurology.
[24] E. Lai,et al. Non-motor Symptoms of Parkinson's Disease , 2007 .
[25] H. Braak,et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen , 2003, Journal of Neural Transmission.
[26] V. Lee,et al. Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.
[27] Anna Kamrowska,et al. [Depression in Parkinson's disease]. , 2009, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[28] H. Braak,et al. Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons , 2007, Acta Neuropathologica.
[29] J. Trojanowski,et al. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases , 2002, Annals of neurology.
[30] H. Braak,et al. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson’s disease: an anatomical study , 2009, Acta Neuropathologica.
[31] C. Polman,et al. Pain in Parkinson's disease and multiple sclerosis: Its relation to the medial and lateral pain systems , 2005, Neuroscience & Biobehavioral Reviews.
[32] Reaction of Lewy bodies with antibodies to phosphorylated and non-phosphorylated neurofilaments , 1986, Neuroscience Letters.
[33] O. Rascol,et al. A study of salivary secretion in Parkinson's disease. , 1999, Clinical neuropharmacology.
[34] E. Kuusisto,et al. Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α‐Synuclein, Ubiquitin, and p62 , 2003, Journal of neuropathology and experimental neurology.
[35] K. Hirokawa,et al. Lewy bodies in the sinoatrial nodal ganglion: Clinicopathological studies , 2004, Pathology international.
[36] A. Siderowf,et al. Premotor Parkinson's disease: Clinical features and detection strategies , 2009, Movement disorders : official journal of the Movement Disorder Society.
[37] W. Jost,et al. Nondipping in Parkinson's Disease , 2011, Parkinson's disease.
[38] E. Benarroch,et al. Neural control of the gastrointestinal tract: Implications for Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[39] D. Dickson,et al. Incidental Lewy body disease and preclinical Parkinson disease. , 2008, Archives of neurology.
[40] Kurt Jellinger,et al. Amygdala pathology in Parkinson's disease , 2004, Acta Neuropathologica.
[41] R. Postuma,et al. Idiopathic REM sleep behavior disorder in the transition to degenerative disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[42] N. Lehman. The ubiquitin proteasome system in neuropathology , 2009, Acta Neuropathologica.
[43] R. Sidman,et al. Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[44] I. Tracey. Nociceptive processing in the human brain , 2005, Current Opinion in Neurobiology.
[45] D. Goldstein,et al. Cardiac sympathetic denervation preceding motor signs in Parkinson disease , 2009, Cleveland Clinic Journal of Medicine.
[46] H. Braak,et al. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered , 2006, Movement disorders : official journal of the Movement Disorder Society.
[47] K. Tredici,et al. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases , 2011, Journal of the Neurological Sciences.
[48] E. Quagliato,et al. Pain in Parkinson's disease: analysis of 50 cases in a clinic of movement disorders. , 2008, Arquivos de neuro-psiquiatria.
[49] W. Poewe,et al. Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model , 2010, Movement disorders : official journal of the Movement Disorder Society.
[50] S. Takeda,et al. Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease , 2004, Acta Neuropathologica.
[51] J. Marinus,et al. Patterns of motor and non-motor features in Parkinson’s disease , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.
[52] Brian Spencer,et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein , 2009, Proceedings of the National Academy of Sciences.
[53] T. Powley,et al. Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease? , 2008, Neuroscience.
[54] P. Croft,et al. The prevalence of pain and pain interference in a general population of older adults: cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP) , 2004, Pain.
[55] Lewy Body‐Related α‐Synucleinopathy in Aging , 2004 .
[56] D. Maraganore,et al. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. , 2009, Archives of neurology.
[57] M. Esiri,et al. Alpha‐synuclein pathology in the olfactory pathways of dementia patients , 2007, Journal of anatomy.
[58] J. Levine,et al. Pain and death: Neurodegenerative disease mechanisms in the nociceptor , 2011, Annals of neurology.
[59] C. Tanner,et al. Association of olfactory dysfunction with incidental Lewy bodies , 2006, Movement disorders : official journal of the Movement Disorder Society.
[60] A. Lang,et al. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder , 2006, Neurology.
[61] H. Reichmann,et al. Beyond tremor and rigidity: non-motor features of Parkinson’s disease , 2009, Journal of Neural Transmission.
[62] H C Schouten,et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[63] H. Braak,et al. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease , 2010, Acta Neuropathologica.
[64] J. Bogousslavsky,et al. Syndromes douloureux de la maladie de Parkinson , 2005 .
[65] H. Braak,et al. Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system , 2000, Journal of Chemical Neuroanatomy.
[66] A. Cuervo,et al. Autophagy and neurodegeneration: when the cleaning crew goes on strike , 2007, The Lancet Neurology.
[67] Udo Rüb,et al. Where Does Parkinson Disease Pathology Begin in the Brain? , 2002, Journal of neuropathology and experimental neurology.
[68] J. Robertson,et al. Pain factors associated with physical disability in a sample of community-dwelling senior citizens. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[69] M. Neunlist,et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease , 2012, Neurobiology of Disease.
[70] Andrew J Lees,et al. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. , 2010, Brain : a journal of neurology.
[71] D. Sulzer,et al. Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease , 2008, Journal of neurochemistry.
[72] C. Tanner,et al. Association of olfactory dysfunction with risk for future Parkinson's disease , 2008, Annals of neurology.
[73] A. Korczyn,et al. Autonomic nervous system disturbances in Parkinson's disease. , 1990, Advances in neurology.
[74] A. Lees,et al. Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study , 2008, Movement disorders : official journal of the Movement Disorder Society.
[75] H. Braak,et al. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunocytochemistry , 1999, Neuroscience Letters.
[76] A. Craig,et al. Pain mechanisms: labeled lines versus convergence in central processing. , 2003, Annual review of neuroscience.
[77] M. Stern,et al. Milestones in Parkinson's disease—Clinical and pathologic features , 2011, Movement disorders : official journal of the Movement Disorder Society.
[78] S. Takeda,et al. Parkinson's disease with involvement of the parasympathetic ganglia , 2004, Acta Neuropathologica.
[79] Amos D. Korczyn,et al. Parkinson's disease: Before the motor symptoms and beyond , 2010, Journal of the Neurological Sciences.
[80] Chris Zarow,et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.
[81] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[82] Aj Lees,et al. Parkinson's disease (vol 373, pg 2055, 2009) , 2009 .
[83] C. Saper,et al. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease , 1985, Annals of neurology.
[84] J. Charcot,et al. Lectures on the diseases of the nervous system: delivered at La Salpêtrìere , 2009 .
[85] Hitoshi Takahashi,et al. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system , 2004, Acta Neuropathologica.
[86] G. Perry,et al. Emerging evidence for the neuroprotective role of α-synuclein , 2006, Experimental Neurology.
[87] A. Kakita,et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. , 2008, Brain : a journal of neurology.
[88] H. Shill,et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.
[89] G. Halliday,et al. The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.
[90] Hitoshi Takahashi,et al. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses , 2004, Acta Neuropathologica.
[91] B. Grahn,et al. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. , 2004, Parkinsonism & related disorders.
[92] B. Ford. Parkinson disease: Pain in Parkinson disease: the hidden epidemic , 2009, Nature Reviews Neurology.
[93] Tianhong Pan,et al. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. , 2008, Brain : a journal of neurology.
[94] H. Shill,et al. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders , 2010, Acta Neuropathologica.
[95] K. Browning,et al. Brainstem circuits regulating gastric function. , 2006, Annual review of physiology.
[96] F. Schmitt,et al. Lewy Body Pathology in Normal Elderly Subjects , 2009, Journal of neuropathology and experimental neurology.
[97] C. Tanner,et al. Bowel movement frequency in late‐life and incidental Lewy bodies , 2007, Movement disorders : official journal of the Movement Disorder Society.
[98] H. Braak,et al. Poor and protracted myelination as a contributory factor to neurodegenerative disorders , 2004, Neurobiology of Aging.
[99] R. Roy,et al. A survey of chronic pain in an elderly population. , 1986, Canadian family physician Medecin de famille canadien.
[100] W. Poewe,et al. Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[101] G. Halliday,et al. Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms , 2008, Experimental Neurology.
[102] A. Davies,et al. Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons , 2004, Journal of Cell Science.
[103] G. Halliday,et al. Specific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease , 1997, Experimental Neurology.
[104] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[105] F. Verhey,et al. Higher incidence of depression preceding the onset of Parkinson's disease: A register study , 2003, Movement disorders : official journal of the Movement Disorder Society.
[106] L. Forno,et al. CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM , 1969, Journal of the American Geriatrics Society.
[107] M. Anlauf,et al. Chemical coding of the human gastrointestinal nervous system: Cholinergic, VIPergic, and catecholaminergic phenotypes , 2003, The Journal of comparative neurology.
[108] W. A. Den Hartog Jager,et al. THE DISTRIBUTION OF LEWY BODIES IN THE CENTRAL AND AUTONOMIC NERVOUS SYSTEMS IN IDIOPATHIC PARALYSIS AGITANS , 1960, Journal of neurology, neurosurgery, and psychiatry.
[109] A. Lagi,et al. Clinostatic Hypertension and Orthostatic Hypotension , 2010, Clinical cardiology.
[110] A. Probst,et al. α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects , 2006, Neuropathology and applied neurobiology.
[111] L. Cote,et al. Primary sensory symptoms in parkinsonism , 1976, Neurology.
[112] H. Soininen,et al. Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease. , 2003, Journal of neuropathology and experimental neurology.
[113] Andrew Siderowf,et al. Parkinson's at risk syndrome: Can Parkinson's disease be predicted? , 2010, Movement disorders : official journal of the Movement Disorder Society.
[114] T. Uchihara,et al. Pale Neurites, Premature α‐Synuclein Aggregates with Centripetal Extension from Axon Collaterals , 2012, Brain pathology.
[115] H. Braak,et al. Neuroanatomy and pathology of sporadic Parkinson's disease. , 2008, Advances in anatomy, embryology, and cell biology.
[116] H. Braak,et al. Parkinson's disease: premotor clinico-pathological correlations. , 2006, Journal of neural transmission. Supplementum.
[117] T. Iwatsubo,et al. Analysis of the Adrenal Gland Is Useful for Evaluating Pathology of the Peripheral Autonomic Nervous System in Lewy Body Disease , 2007, Journal of neuropathology and experimental neurology.
[118] James T Becker,et al. Research evaluation and prospective diagnosis of dementia with Lewy bodies. , 2002, Archives of neurology.
[119] D. Dickson,et al. Evidence in favor of Braak staging of Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[120] B. Walker,et al. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. , 2000, Journal of spinal disorders.
[121] S. Daniel,et al. Commentary Qjm Is Parkinson's Disease a Primary Olfactory Disorder? , 2022 .
[122] M. Lapeyre-Mestre,et al. Comparison of chronic analgesic drugs prevalence in Parkinson’s disease, other chronic diseases and the general population , 2009, PAIN®.
[123] P. Brundin,et al. Can Parkinson's disease pathology be propagated from one neuron to another? , 2012, Progress in Neurobiology.
[124] P. Brundin,et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. , 2011, The Journal of clinical investigation.
[125] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[126] Léon Plaghki,et al. Nociceptive processing in the human brain of infrequent task-relevant and task-irrelevant noxious stimuli. A study with event-related potentials evoked by CO2 laser radiant heat stimuli , 2003, Pain.
[127] A. Lang. A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials , 2011, Movement disorders : official journal of the Movement Disorder Society.
[128] R. Pfeiffer,et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation , 1995, The Lancet.
[129] H. Braak,et al. Nerve cells immunoreactive for p62 in select hypothalamic and brainstem nuclei of controls and Parkinson’s disease cases , 2010, Journal of Neural Transmission.
[130] K. Iwanaga,et al. Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases , 1999, Neurology.
[131] D. Yarnitsky,et al. Quantitative measurement of pain sensation in patients with Parkinson disease , 2004, Neurology.
[132] H. Reichmann,et al. Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice , 2010, PloS one.
[133] H. Reichmann,et al. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes , 2009, Movement disorders : official journal of the Movement Disorder Society.
[134] F. Micheli,et al. Quantitative study of salivary secretion in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[135] David Boltz,et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration , 2009, Proceedings of the National Academy of Sciences.
[136] T. Iwatsubo,et al. Lewy Body Pathology Involves Cutaneous Nerves , 2008, Journal of neuropathology and experimental neurology.
[137] C. Leboeuf‐Yde,et al. The Prevalence of Low Back Pain in the Literature A Structured Review of 26 Nordic Studies From 1954 to 1993 , 1995, Spine.
[138] H. Berendse,et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.
[139] Thomas Gasser,et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.
[140] L. Forno,et al. Ultrastructure of Lewy bodies in the stellate ganglion , 1976, Acta Neuropathologica.
[141] J. Langston,et al. The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.
[142] O. Rascol,et al. Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP survey , 2008, Movement disorders : official journal of the Movement Disorder Society.
[143] Bernard Laurent,et al. Prevalence of chronic pain with neuropathic characteristics in the general population , 2008, PAIN.
[144] A. Berardelli,et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. , 2008, Archives of neurology.
[145] Smita Patel,et al. Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates , 2005, The Journal of Neuroscience.
[146] Pablo Martinez-Martin,et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.
[147] D. Dickson. α-Synuclein and the Lewy body disorders , 2001 .
[148] Satoshi Orimo,et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease , 2005, Acta Neuropathologica.
[149] S. Resnick,et al. Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA) , 2005, Journal of neuropathology and experimental neurology.
[150] S. Daniel,et al. The anterior olfactory nucleus in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.
[151] D. Aarsland,et al. Pain and its relationship to depression in Parkinson disease. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[152] Markus Tolnay,et al. The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.
[153] Igor Tsigelny,et al. Cell-to-cell transmission of non-prion protein aggregates , 2010, Nature Reviews Neurology.
[154] Hitoshi Takahashi,et al. The intermediolateral nucleus and Clarke’s column in Parkinson’s disease , 1997, Acta Neuropathologica.
[155] D. Dickson,et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease , 2008, Acta Neuropathologica.
[156] K. Wakabayashi,et al. Incidental Lewy body disease restricted to the heart and stellate ganglia , 2009, Movement disorders : official journal of the Movement Disorder Society.
[157] B. Hyman,et al. Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.
[158] Anette Schrag,et al. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? , 2010, Movement disorders : official journal of the Movement Disorder Society.
[159] E. Wolters,et al. Management of non-motor symptoms in advanced Parkinson disease , 2008, Journal of the Neurological Sciences.
[160] H. Shill,et al. Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders , 2008, Acta Neuropathologica.
[161] B. Collett,et al. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.
[162] L. Montero,et al. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology , 2009, Neurobiology of Disease.
[163] J. Trojanowski,et al. Neuropathology of synuclein aggregates , 2000, Journal of neuroscience research.
[164] E. Porta. Pigments in Aging: An Overview , 2002, Annals of the New York Academy of Sciences.
[165] Mark W. Mahowald,et al. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.
[166] D. Broetz,et al. Radicular and nonradicular back pain in Parkinson's disease: A controlled study , 2007, Movement disorders : official journal of the Movement Disorder Society.
[167] W. Poewe,et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[168] K. Jellinger,et al. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.
[169] Dennis W. Dickson,et al. Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.
[170] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.
[171] K. Jellinger. Morphological substrates of dementia in parkinsonism. A critical update. , 1997, Journal of neural transmission. Supplementum.
[172] K. Krogh. Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .
[173] L. Geffen,et al. Age-related loss of dorsal vagal neurons in Parkinson's disease , 1992, Neurology.
[174] C. Tanner,et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[175] A. Tennant,et al. Changing profile of joint disorders with age: findings from a postal survey of the population of Calderdale, West Yorkshire, United Kingdom. , 1992, Annals of the rheumatic diseases.
[176] H. Kretzschmar,et al. Early Spread of Scrapie from the Gastrointestinal Tract to the Central Nervous System Involves Autonomic Fibers of the Splanchnic and Vagus Nerves , 2001, Journal of Virology.
[177] A M Graybiel,et al. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[178] W. Oertel,et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. , 2004, Brain : a journal of neurology.
[179] T. Dawson,et al. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders , 2001, Trends in Neurosciences.
[180] Pain as a sequela of Parkinson disease. , 2004, Australian family physician.
[181] Massimiliano Valeriani,et al. Abnormal processing of the nociceptive input in Parkinson’s disease: A study with CO2 laser evoked potentials , 2008, PAIN.
[182] V. Calabrese,et al. PROJECTED NUMBER OF PEOPLE WITH PARKINSON DISEASE IN THE MOST POPULOUS NATIONS, 2005 THROUGH 2030 , 2007, Neurology.
[183] A. Kakita,et al. Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease , 2011, Neuropathology and applied neurobiology.
[184] K. Wakabayashi,et al. Neuropathology of autonomic nervous system in Parkinson's disease. , 1997, European neurology.
[185] F. Micheli,et al. Hyposialorrhea as an early manifestation of Parkinson disease , 2009, Autonomic Neuroscience.
[186] D. Maraganore,et al. Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? , 2011, Neurobiology of Aging.
[187] J. Jankovic,et al. Shoulder pain: a presenting symptom of Parkinson disease. , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[188] H. Reichmann,et al. Biopsies of olfactory epithelium in patients with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[189] S. Kaasa,et al. Short Form 36 (SF-36) health survey: normative data from the general Norwegian population , 1998, Scandinavian journal of social medicine.
[190] D. Dickson,et al. Neuropathology underlying clinical variability in patients with synucleinopathies , 2011, Acta Neuropathologica.
[191] S. Brookes,et al. Anatomy and physiology of the enteric nervous system , 2000, Gut.
[192] D. Dickson,et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[193] C. Marsden,et al. PAINFUL PARKINSON'S DISEASE , 1986, The Lancet.
[194] Cecil M. Burchfiel,et al. Environmental, life-style, and physical precursors of clinical Parkinson’s disease: recent findings from the Honolulu-Asia Aging Study , 2003, Journal of Neurology.
[195] C. Hawkes,et al. Olfaction in neurodegenerative disorder. , 2006, Advances in oto-rhino-laryngology.
[196] H. Shill,et al. Incidental Lewy body disease: Clinical comparison to a control cohort , 2010, Movement disorders : official journal of the Movement Disorder Society.
[197] N. Talley. Medical records documentation of constipation preceding Parkinson disease: A case-control study , 2010 .
[198] D. German,et al. Axonal and transneuronal transport in the transmission of neurological disease: Potential role in system degenerations, including alzheimer's disease , 1987, Neuroscience.
[199] D. Dickson,et al. Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies , 2010, Acta Neuropathologica.
[200] Y Mizuno,et al. [Clinical subtypes of Parkinson's disease]. , 1993, No to shinkei = Brain and nerve.
[201] S. Sara. The locus coeruleus and noradrenergic modulation of cognition , 2009, Nature Reviews Neuroscience.
[202] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[203] W. Koller,et al. Sensory symptoms in Parkinson's disease , 1984, Neurology.
[204] E. Szabadi,et al. Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part I: Principles of Functional Organisation , 2008, Current neuropharmacology.
[205] A. Bonnet,et al. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death , 2010, Neurobiology of Aging.
[206] C. Adler,et al. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease , 2008, Acta Neuropathologica.
[207] H. Braak,et al. Pathology associated with sporadic Parkinson's disease--where does it end? , 2006, Journal of neural transmission. Supplementum.
[208] R. Walker,et al. A survey of pain in idiopathic Parkinson's disease. , 2006, Journal of pain and symptom management.
[209] T. Krause,et al. Impaired cardiac uptake of meta‐[123 I]iodobenzylguanidine in Parkinson's disease with autonomic failure , 1998, Acta neurologica Scandinavica.
[210] Johannes B Reitsma,et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies , 2006, BMC medical research methodology.
[211] J. Trojanowski,et al. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. , 1999, Experimental neurology.
[212] J. Loge,et al. Pain in Parkinson’s disease: Prevalence and characteristics , 2009, PAIN®.
[213] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[214] M. Yoshimura,et al. Lewy body disease with and without dementia: a clinicopathological study of 35 cases. , 1988, Clinical neuropathology.
[215] Kiyoharu Inoue,et al. Incidence and Extent of Lewy Body-Related &agr;-Synucleinopathy in Aging Human Olfactory Bulb , 2008, Journal of neuropathology and experimental neurology.
[216] K. Shannon,et al. Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[217] R. Postuma,et al. Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder , 2010, Movement disorders : official journal of the Movement Disorder Society.
[218] D Martino,et al. Pain and motor complications in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.